Article metrics

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000